EP0383361 - 1-Beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.10.1996 Database last updated on 15.06.2024 | Most recent event Tooltip | 11.10.1996 | Application deemed to be withdrawn | published on 27.11.1996 [1996/48] | Applicant(s) | For all designated states VIRATEK, INC. 3300 Hyland Avenue Costa Mesa California 92626 / US | [N/P] |
Former [1990/34] | For all designated states VIRATEK, INC. 3300 Hyland Avenue Costa Mesa California 92626 / US | Inventor(s) | 01 /
Smith, Robert Angus 221, 17th Street Santa Monica, California 90402 / US | 02 /
Fernandez, Humberto 3571 Myrtle Street Irvine, California 92714 / US | [1990/34] | Representative(s) | Goldin, Douglas Michael, et al J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
Former [1990/34] | Goldin, Douglas Michael, et al J.A. KEMP & CO. 14, South Square Gray's Inn London WC1R 5LX / GB | Application number, filing date | 90105678.8 | 16.04.1985 | [1990/34] | Priority number, date | US19840666252 | 29.10.1984 Original published format: US 666252 | [1990/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0383361 | Date: | 22.08.1990 | Language: | EN | [1990/34] | Type: | A3 Search report | No.: | EP0383361 | Date: | 16.06.1993 | Language: | EN | [1993/24] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.04.1993 | Classification | IPC: | A61K31/70 | [1990/34] | CPC: |
A61K31/7004 (EP);
A61K31/41 (KR);
A61P11/00 (EP);
A61P31/12 (EP);
C07H19/056 (EP)
| Designated contracting states | AT, CH, DE, FR, GB, IT, LI, NL, SE [1990/34] | Title | German: | 1-Beta-D-ribofuranosyl-1,2,4-triazol-3-carboxamid für die Verwendung bei der medizinischen Behandlung von Menschen | [1990/34] | English: | 1-Beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans | [1990/34] | French: | 1-Bêta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide pour l'emploi dans le traitement médical d'humains | [1990/34] | File destroyed: | 20.04.2002 | Miscellaneous | EPB 1995/07: Teilanmeldung 94118300.6 eingereicht am 16/04/85 | EPB 1995/07: Divisional application 94118300.6 filed on 16/04/85 | EPB 1995/07: Demande divisionnaire 94118300.6 déposée le 16/04/85 | Examination procedure | 26.03.1990 | Examination requested [1990/34] | 11.05.1994 | Despatch of a communication from the examining division (Time limit: M06) | 27.04.1995 | Reply to a communication from the examining division | 20.10.1995 | Despatch of a communication from the examining division (Time limit: M06) | 01.05.1996 | Application deemed to be withdrawn, date of legal effect [1996/48] | 28.06.1996 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1996/48] | Parent application(s) Tooltip | EP85302644.1 / EP0181050 | Divisional application(s) | EP94118300.6 / EP0643970 | Request for further processing for: | 27.04.1995 | Request for further processing filed | 27.04.1995 | Full payment received (date of receipt of payment) Request granted | 15.05.1995 | Decision despatched | Fees paid | Renewal fee | 26.03.1990 | Renewal fee patent year 03 | 26.03.1990 | Renewal fee patent year 04 | 26.03.1990 | Renewal fee patent year 05 | 26.03.1990 | Renewal fee patent year 06 | 18.09.1991 | Renewal fee patent year 07 | 25.09.1992 | Renewal fee patent year 08 | 15.03.1993 | Renewal fee patent year 09 | 14.04.1994 | Renewal fee patent year 10 | 13.04.1995 | Renewal fee patent year 11 | 09.04.1996 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 02.05.1991 | 07   M06   Fee paid on   18.09.1991 | 04.05.1992 | 08   M06   Fee paid on   25.09.1992 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - ANTIVIRAL RES., vol. 1, no. 1, March 1981, pages 47-53, Elsevier/North-Holland Biomedical Press; R.W. SIDWELL et al.: "Bovine leukemia virus inhibition in vitro by ribavirin" | [X] - PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 148, no. 3, March 1975, pages 854-858, The Society for Experimental Biology and Medicine; R.W. SIDWELL et al.: "Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on friend leukemia virus infections in mice (38647)" | [X] - ARCHIVES INTERNATIONALES DE PHYSIOLOGIE ET DE BIOCHIMIE, vol. 87, no. 2, May 1979, pages 353-395; E. DE CLERCQ: "New trends in antiviral chemotherapy" | [X] - ANTIBIOTICS CHEMOTHER., vol. 27, 1980, pages 208-232; R.W. SIDWELL et al.: "5-Membered azaheterocycles and their nucleosides" | [X] - ADVANCES IN COMPARATIVE LEUKEMIA RESEARCH, PROC. INT. SYMP., 9th, (ed. D.S. YOHN), (Elsevier, Amsterdam, NL), 1980, pages 123-124; Y.C. CHEN et al.: "Effects of 3-deazaguanine and virazole on rous sarcoma viruses" | [X] - DRUGS, vol. 22, no. 2, August 1981, pages 111-128, ADIS Press Australasia Pty Ltd; T.-W. CHANG et al.: "Ribavirin and inosiplex: a review of their present status in viral diseases" | [XP] - LANCET, vol. 2, no. 8416, 15th December 1984, pages 1367-1369; J.B. McCORMICK et al.: "Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes" |